{"organizations": [], "uuid": "003547728dfd312958b711f4a9b3f402954e2c1e", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-paratek-pharmaceuticals-prices-140/brief-paratek-pharmaceuticals-prices-140-mln-of-convertible-senior-subordinated-notes-due-2024-idUSASC09WI0", "country": "US", "domain_rank": 408, "title": "BRIEF-Paratek Pharmaceuticals Prices $140 Mln Of Convertible Senior Subordinated Notes Due 2024", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-19T15:48:00.000+03:00", "replies_count": 0, "uuid": "003547728dfd312958b711f4a9b3f402954e2c1e"}, "author": "", "url": "https://www.reuters.com/article/brief-paratek-pharmaceuticals-prices-140/brief-paratek-pharmaceuticals-prices-140-mln-of-convertible-senior-subordinated-notes-due-2024-idUSASC09WI0", "ord_in_thread": 0, "title": "BRIEF-Paratek Pharmaceuticals Prices $140 Mln Of Convertible Senior Subordinated Notes Due 2024", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-paratek pharmaceuticals prices", "sentiment": "negative"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "paratek pharmaceuticals inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 19, 2018 / 12:52 PM / Updated 12 minutes ago BRIEF-Paratek Pharmaceuticals Prices $140 Mln Of Convertible Senior Subordinated Notes Due 2024 Reuters Staff \nApril 19 (Reuters) - Paratek Pharmaceuticals Inc: \n* PARATEK PHARMACEUTICALS, INC. PRICES $140 MILLION OF CONVERTIBLE SENIOR SUBORDINATED NOTES DUE 2024 \n* PARATEK PHARMACEUTICALS INC - NOTES WILL PAY INTEREST SEMIANNUALLY IN ARREARS ON MAY 1 AND NOVEMBER 1 OF EACH YEAR AT RATE OF 4.75% PER YEAR \n* PARATEK PHARMACEUTICALS INC - NOTES WILL MATURE ON MAY 1, 2024 Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-04-19T15:48:00.000+03:00", "crawled": "2018-04-19T16:11:54.002+03:00", "highlightTitle": ""}